This webinar has concluded.

Oncology Utilization Management: Best practices for using analytics and real-world data to make patient treatment decisions

A Live Webinar Panel Discussion

Thursday, May 28, 2020

Over the past decade, the oncology landscape has undergone dramatic changes, through an unprecedented number of new anti-cancer treatments that have increased both the complexity and cost of care.

Oncology focused analytics, and real-world evidence can help health plans make educated predictions on future trends, which will benefit patients by ensuring they receive the right drugs and the right support to fund their treatment.

In this webinar, Oncology Analytics will discuss approaches and best practices for the use of real-world data and analytics for oncology utilization management, using their platform to demonstrate.

During this webinar, the following topics will be explored:

  • How to combine a health plan’s claims data with oncology-focused EMR data (pathology, labs, etc.) to get a 360 view of a patient’s status as it relates to the requested therapy.
  • How to leverage real-world data and analytics to understand your provider network at a deeper level.
  • How to utilize prior authorization technology to make the shift from faxes to online submission and immediate adjudication.
  • How to organize claims and clinical data to get a better understanding of cancer drug therapies, including drug effects by disease and the cost effects of biosimilars.

Featured Speakers

Rick Dean, CEO
Oncology Analytics

Mr. Dean has focused his career on creating innovative data and analytics strategies for healthcare companies. Before Oncology Analytics, Mr. Dean was with Optum, the healthcare services arm of UnitedHealth Group (NYSE: UNH), where he was a founding member of Optum Ventures, a venture capital fund focused on digital health innovation and previously led global growth for Optum Analytics.

Dr. Andrew Norden, Chief Medical Officer
Oncology Analytics

An accomplished neuro-oncologist, Dr. Norden is a passionate leader and advocate for the use of data and analytics to improve the lives of cancer patients through better treatment options and outcomes. Before joining Oncology Analytics, Dr. Norden served as Chief Medical Officer of Cota Healthcare; an oncology company focused on the curation and use of real-world data and evidence for cancer care and research. Dr. Norden also held several positions at the Dana-Farber Cancer Institute in Boston, including Associate Chief Medical Officer and Medical Director of Satellites and Network Affiliates.

Sara Zywicki, SVP, Product Management
Oncology Analytics

Ms. Zywicki has a proven track record for the development and execution of analytics-driven solutions in the healthcare market. Before Oncology Analytics, Ms. Zywicki was the VP of Product Management for SPH Analytics, a leader in healthcare analytics and population health management.

  • This field is for validation purposes and should be left unchanged.

Insight Exchange Network
P.O. Box 3867
Santa Cruz, CA 95062
(831) 431-6668
[email protected]
Privacy Policy


Website by WebHolism